Northern Trust’s OKYO Pharma OKYO Stock Holding History

Northern Trust’s Portfolio OKYO Stock Details OKYO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-57,158	Closed	-$114K	–	4521
2025 Q3	$114K	Buy	+57,158	New	+$146K	﹤0.01%	4104

Other funds holding OKYO

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

EFG International Zurich $4.67B AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust's OKYO Position: Q4 2025 in Review

Northern Trust sold out of OKYO Pharma (OKYO) in Q4 2025, closing a stake of 57,158 shares — an estimated $114K sold.

Northern Trust first reported a position in OKYO in Q3 2025 and held it in 1 quarter. The position peaked at $114K in Q3 2025. 10 funds tracked by Wall St. Rank hold OKYO as of Q4 2025.

Northern Trust reported no remaining OKYO Pharma position as of Q4 2025 after selling out during the quarter.
Northern Trust sold 57,158 OKYO Pharma shares in Q4 2025, an estimated $114K.
Northern Trust first reported a position in OKYO Pharma in Q3 2025 and held it in 1 quarter.
Northern Trust's OKYO Pharma position peaked at $114K in Q3 2025.
10 funds tracked by Wall St. Rank held OKYO Pharma as of Q4 2025.

Based on Northern Trust's 13F filing for Q4 2025, filed 17 Feb 2026.